Key result
Comprehensive cardiac risk assessment, including the use of cardiac biomarkers and imaging, is essential for the optimal management of cardiac disease in cancer survivors.
Population
Cancer survivors
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports cardiac risk assessment with biomarkers and imaging in cancer survivors; leaves open optimal protocols pending prospective validation.
Structured PICO
P
Population
Cancer survivors
This expert dialogue highlights the necessity of comprehensive cardiac risk assessment, including biomarkers and imaging, for managing cardiac toxicity in cancer survivors.
Cite This Study
Lenihan et al. (2013) conducted a review in Cardiac disease in cancer survivors. Comprehensive cardiac risk assessment, including the use of cardiac biomarkers and imaging, is essential for the optimal management of cardiac disease in cancer survivors.